O75164 (KDM4A_HUMAN) Homo sapiens (Human)

Lysine-specific demethylase 4A UniProtKBInterProSTRINGInteractive Modelling

1064 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

85 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H4(1-15)R3me2s PEPTIDE
5fwe
 Heteromer
P62805; 		3-355
1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL;
Assess
Crystal structure of human KDM4A complexed with co-substrate analog NOG and histone H3 peptide with…
6hgt
 Heteromer
P68431; 		5-354
2×ZN; 1×OGA;
Assess
Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9
2ox0
 Heteromer
P68431; 		7-355
1×NI; 1×ZN; 1×CL; 1×OGA;
Assess
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41)
2ybp
 Heteromer
Q16695; 		7-355
1×NI; 1×ZN; 1×GOL; 1×2HG;
Assess
Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9
2ot7
 Heteromer
P68431; 		7-355
1×NI; 1×ZN; 1×OGA;
Assess
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (16-35)
4v2w
 Heteromer
Q16695; 		7-354
1×NI; 1×ZN; 1×CL; 1×OGA; 1×GOL;
Assess
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9
2oq6
 Heteromer
P68431; 		8-355
1×NI; 1×ZN; 1×OGA;
Assess
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (25-29) ARK(me3)SA
4v2v
 Heteromer
Q16695; 		7-354
1×OGA; 1×NI; 1×ZN;
Assess
JMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41)
2ybs
 Heteromer
Q16695; 		8-355
1×NI; 1×ZN; 1×GOL; 1×S2G;
Assess
The complex structure of JMJD2A and trimethylated H3K36 peptide
2p5b
 Heteromer
P84239; 		2-348
1×ZN; 1×FE2; 1×OGA; 2×OXY;
Assess
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Histone H1.4(18-32)K26me3 peptide (15-mer)
6h8p
 Heteromer
P10412; 		9-354
1×NI; 1×ZN; 1×CL; 1×OGA; 3×GOL;
Assess
Histone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to N-oxalyl-D-…
3u4s
 Heteromer
P68431; 		8-352
1×NI; 1×ZN; 1×08P;
Assess
JMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptide
2qqs
 Heteromer
P62805; 		897-1005
Assess
Crystal structure of double tudor domain of human lysine demethylase KDM4A complexed with histone H…
5d6y
 Heteromer
P68431; 		898-1005
Assess
JMJD2A/ KDM4A COMPLEXED WITH NI(II) AND Macrocyclic PEPTIDE Inhibitor CP2 (13-mer)
5ly1
homo-4-mer5-355
4×NI; 4×ZN; 3×CL; 5×GOL; 3×PPI;
Assess
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Macrocyclic PEPTIDE Inhibitor CP2_R6Kme3 (13-mer)
5ly2
homo-4-mer5-354
4×NI; 4×ZN; 4×OGA; 5×GOL; 5×CL;
Assess
Crystal structure of JMJD2A complexed with 3,4-dihydroxybenzoic acid
7eqv
homo-2-mer8-347
2×DHB; 2×NI; 2×ZN; 2×CL;
Assess
Crystal structure of JMJD2A complexed with bipyridyl inhibitor
3pdq
monomer3-355
1×NI; 1×ZN; 1×KC6; 4×CL; 1×NA;
Assess
Crystal Structure of KDM4A with compound YP-02-145
6g5x
monomer3-353
1×ZN; 3×NI; 2×EDO; 2×CIT; 1×GOL;
Assess
Crystal structure of human JMJD2A in complex with compound 30
5a7q
monomer3-353
2×MN; 1×KCH; 1×ZN; 2×CL;
Assess
Crystal structure of human JMJD2A in complex with pyruvate
5fyi
monomer4-354
1×NI; 2×PYR; 1×DMS; 9×EDO; 1×ZN;
Assess
Crystal structure of human JMJD2A in complex with compound 42
5a7o
monomer4-354
1×SO4; 1×7WH; 11×EDO; 1×ZN; 1×MN; 1×DMS;
Assess
Crystal Structure of JMJD2A Complexed with Inhibitor
3rvh
monomer3-353
1×NI; 1×ZN; 1×HQ2; 1×GOL;
Assess
Crystal structure of human JMJD2A in complex with compound 40
5a80
monomer4-354
1×SO4; 1×MN; 1×9CJ; 1×ZN; 5×EDO;
Assess
Crystal structure of human JMJD2A in complex with fumarate
5fyh
monomer4-354
1×ZN; 1×FUM; 1×SO4; 1×MN; 1×EDO;
Assess
Crystal structure of human JMJD2A in complex with compound 43
5a7n
monomer4-354
1×MN; 1×ZN; 5×EDO; 1×SO4; 1×VAO;
Assess
Crystal Structure of KDM4A with Compound 14
6cg1
monomer5-354
1×NI; 1×ZN; 1×QC1;
Assess
Crystal structure of human KDM4A in complex with compound 58
5f37
monomer5-354
2×ZN; 1×N5J; 12×EDO; 2×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 54j
5f3i
monomer6-355
2×ZN; 1×5UJ; 1×DMS;
Assess
Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid
2vd7
monomer6-355
1×NI; 1×ZN; 1×PD2;
Assess
Crystal structure of human JMJD2A in complex with compound 36
5a7p
monomer4-353
1×SO4; 1×MN; 1×ZN; 4×EDO; 1×6Z1; 1×DMS;
Assess
Crystal Structure of JMJD2A Complexed with Inhibitor
4gd4
monomer5-354
1×NI; 1×ZN; 1×CL; 1×0WS;
Assess
Crystal structure of human JMJD2A in complex with D-threo-isocitrate
5fy8
monomer4-353
1×NI; 1×ZN; 1×N81; 1×DMS; 3×EDO;
Assess
Crystal Structure of Human KDM4 with Small Molecule Inhibitor QC5714
5vmp
monomer5-354
1×NI; 1×ZN; 1×9FJ;
Assess
Crystal Structure of KDM4A with compound YP-03-038
6g5w
monomer4-352
1×ZN; 2×NI; 2×EDO; 2×CIT;
Assess
Crystal structure of human KDM4A in complex with compound 17f
6h4r
monomer6-354
2×ZN; 1×FQB; 1×DMS; 1×GOL;
Assess
Crystal structure of human KDM4A in complex with compound 34g
6h4v
monomer6-354
2×ZN; 1×FQN; 1×CL; 2×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 54a
5f3e
monomer6-354
2×ZN; 1×5UO; 1×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 16a
6h4p
monomer6-354
2×ZN; 1×FQ5; 3×DMS; 1×CL;
Assess
Crystal structure of human JMJD2A in complex with compound 14a
4ura
monomer4-352
1×EDO; 1×SO4; 1×NI; 1×ZN; 1×LEL;
Assess
Crystal structure of human KDM4A in complex with compound 17b
6h4x
monomer6-354
2×ZN; 1×FNQ; 1×DMS; 1×GOL; 1×CL;
Assess
Crystal structure of the catalytic core domain of jmjd2a
2gp3
monomer2-350
1×ZN; 1×FE2;
Assess
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE
2ybk
monomer7-355
1×NI; 1×ZN; 1×CL; 1×2HG;
Assess
Crystal Structure of human JMJD2A complexed with KDOOA011340
5f5i
monomer4-352
1×NI; 1×ZN; 1×SO4; 1×5V1;
Assess
JMJD2A in complex with Ni(II) and alpha-Ketoglutarate
5tvr
monomer6-353
1×NI; 1×AKG; 1×ZN;
Assess
JMJD2A Complexed with Daminozide
4ai9
monomer8-355
1×NI; 1×ZN; 1×CL; 2×DZA;
Assess
Crystal Structure of KDM4A with Compound 8
6cg2
monomer7-354
1×NI; 1×ZN; 1×QC2;
Assess
Crystal structure of human KDM4A in complex with compound 19a
6h4t
monomer7-354
2×ZN; 1×FOW; 1×CL;
Assess
JMJD2A COMPLEXED WITH 8-HYDROXYQUINOLINE-4-CARBOXYLIC ACID
4bis
monomer8-355
1×NI; 1×ZN; 1×CL; 1×8HQ; 1×GOL;
Assess
JMJD2A in complex with Ni(II)
5tvs
monomer6-353
1×NI; 1×ZN;
Assess
The complex structure of JMJD2A and monomethylated H3K36 peptide
2pxj
monomer2-348
1×ZN; 1×FE2; 1×OGA;
Assess
The crystal structure of JMJD2A complexed with Ni and N-oxalylglycine
2oq7
monomer8-354
1×NI; 1×ZN; 1×OGA;
Assess
Crystal structure of human KDM4A in complex with compound 18a
6h4o
monomer8-354
2×ZN; 1×FQH; 1×GOL; 1×CL;
Assess
Crystal structure of catalytic core domain of jmjd2A complexed with alpha-Ketoglutarate
2gp5
monomer2-348
1×ZN; 1×FE2; 1×AKG;
Assess
Crystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinate
2q8d
monomer1-347
1×NI; 1×ZN; 1×SIN;
Assess
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36
2os2
monomer8-354
1×NI; 1×ZN; 1×OGA;
Assess
Crystal structure of human KDM4A in complex with compound 34a
6h4q
monomer7-353
2×ZN; 1×FO2; 2×GOL; 1×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 16m
6h4s
monomer8-354
2×ZN; 1×FQE; 3×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 53a
5f3g
monomer8-354
2×ZN; 1×5UL; 2×DMS;
Assess
Crystal structure of JMJD2A complexed with 5-carboxy-8-hydroxyquinoline
3njy
monomer8-354
1×NI; 1×ZN; 1×8XQ;
Assess
Crystal structure of human KDM4A in complex with compound 19d
6h4w
monomer9-355
2×ZN; 1×FQQ; 1×DMS; 1×CL;
Assess
The Crystal Structure of JMJD2A(M1-L359) from Biortus.
8wd3
monomer9-355
1×NI; 1×ZN;
Assess
Crystal structure of human KDM4A in complex with compound 15
5f2s
monomer9-354
2×ZN; 1×5TZ; 7×EDO; 2×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 34b
6h4u
monomer8-353
2×ZN; 1×FO2; 1×DMS; 1×GOL; 1×CL;
Assess
Crystal structure of human JMJD2A in complex with succinate
5fyc
monomer8-353
1×NI; 1×ZN; 1×FUM; 5×EDO; 1×SO4;
Assess
Crystal structure of human JMJD2A in complex with compound 35
5a7w
monomer8-353
1×SO4; 1×35M; 1×MN; 1×ZN; 2×EDO; 1×DMS;
Assess
Crystal structure of human KDM4A in complex with compound 17e
6h4y
monomer8-353
2×ZN; 1×FO8; 1×CL;
Assess
Crystal structure of human KDM4A in complex with compound 16
5f2w
monomer9-354
2×ZN; 1×5UP; 3×EDO; 1×DMS;
Assess
STRUCTURE OF JMJD2A COMPLEXED WITH INHIBITOR 10A
2wwj
monomer8-353
1×NI; 1×ZN; 1×Y28;
Assess
Crystal structure of human KDM4A in complex with compound 37
5f39
monomer9-354
2×ZN; 1×5UB; 4×DMS;
Assess
Crystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutarate
2q8c
monomer3-347
1×NI; 1×ZN; 1×AKG;
Assess
Crystal structure of human KDM4A in complex with compound 52d
5f3c
monomer10-354
2×ZN; 1×5U8; 4×DMS; 1×GOL;
Assess
Crystal Structure of KDM4 with the Small Molecule Inhibitor QC6352
5vgi
monomer9-353
1×NI; 1×ZN; 1×9DJ;
Assess
Crystal structure of human JMJD2A in complex with compound 44
5a7s
monomer10-354
1×MN; 1×ZN; 7×EDO; 1×S2X; 1×DMS;
Assess
Crystal structure of human JMJD2A in complex with compound KDOAM20A
5fpv
monomer11-355
1×MN; 1×MMK; 1×ZN; 3×NI;
Assess
inhibitors of JumonjiC domain-containing histone demethylases
5anq
monomer10-353
1×5YQ; 1×FE2; 2×SO4; 1×ZN; 3×CL;
Assess
Crystal structure of human KDM4A in complex with compound 40
5f32
monomer11-354
2×ZN; 1×5V7; 1×DMS; 1×EDO; 1×GOL;
Assess
Specificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylase
2q8e
monomer3-346
1×NI; 1×ZN; 1×OGA;
Assess
JMJD2A hybrid tudor domains
2qqr
monomer897-1011
3×SO4;
Assess
Crystal structure of double tudor domain of human lysine demethylase KDM4A
5d6w
monomer897-1011
1×SRT;
Assess
Crystal structure of double tudor domain of human lysine demethylase KDM4A
5d6x
monomer897-1011
2×SO4;
Assess
Double tudor domain structure
2gf7
monomer897-1011
1×SO4;
Assess
double tudor domain complex structure
2gfa
monomer895-1008
Assess
The Crystal Structure of human JMJD2A Tudor domain from Biortus
7d4a
monomer898-1011
1×SO4;
Assess
Crystal structure of KDM4A tandem TUDOR domain in complex with a tri-methyl lysine competitive inhi…
5var
monomer897-1004
1×92Y;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5tvs.1.Amonomer0.866-353
1×NI; 1×ZN;100.00
Assess
2gf7.3.Amonomer0.81897-1011
100.00
Assess
6u04.1.Amonomer0.59732-888
4×ZN;39.35
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25d6w.3.Amonomer0.78314-428
1×SRT;100.00
Assess
Isoform 22xdp.1.Amonomer0.63316-431
67.52
Assess
Isoform 25erc.1.Amonomer0.59148-304
3×ZN;39.87
Assess
Isoform 25zcj.1.Cmonomer0.56317-437
24.11
Assess